HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

6.640

-0.245-3.56%

Volume:996.40K

Turnover:6.58M

Market Cap:2.87B

PE:1.01K

High:6.880

Open:6.800

Low:6.350

Close:6.885

52wk High:48.800

52wk Low:6.350

Shares:432.00M

HK Float Shares:323.00M

Volume Ratio:0.69

T/O Rate:0.31%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.007

ROE:0.21%

ROA:-0.83%

PB:1.82

PE(LYR):1,006.06

PS:5.61

Loading ...

Overview Company News Filings

CF PharmTech Spends HKD 499,600 to Buy Back 74,800 Shares on October 7

CF PharmTech repurchases 74,800 H-shares, boosting treasury stock to 2.02 million units

Bulletin Express

CF PharmTech Reduces Outstanding H-Shares by 0.02% via HK$0.50 Million Buyback

Bulletin Express

CF PharmTech Monthly Update: Share Capital Steady at RMB 433.73 Million; 337.80 Thousand H-Shares Moved to Treasury in September 2026

Bulletin Express

Operating Cash Flow Turns Positive Sharply and Operating Efficiency Jumps Significantly: CF PharmTech (02652) Interim Report Releases Key Signals

CF PharmTech Core Management Voluntarily Extends Share Lock-Up by Six Months

Bulletin Express

CF PharmTech Core Management Voluntarily Extends Share Lock-Up Period by Six Months

CF PharmTech Repurchases 71,800 Shares for HK$499,700 on October 2

CF PharmTech Buys Back 71,800 H Shares, Treasury Stock Climbs to 1.81 Million

Bulletin Express

CF PHARMTECH: Bill Wenqing Liang Acquires Shares, Long Position Rises to 18.74%

CF PHARMTECH: Pyramid Investment Limited Acquires Shares, Long Position Rises to 14.3%

CF PHARMTECH: Li Li Bovet Acquires Shares, Long Position Rises to 18.74%

CF PharmTech Buys Back 144,600 H Shares, Treasury Stock Rises to 1.73 Million

Bulletin Express

CF PharmTech Adds 67,900 H Shares to Treasury via HK$0.49 Million Buyback

Bulletin Express

CF PharmTech Spends HK$489,100 to Buy Back 67,900 Shares on September 29

CF PharmTech Repurchases 125,300 Shares for HK$948,800 on September 28

AI-Driven Innovation at the Source: Targeting a Globally Scarce Inhaled Anti-Inflammatory Pipeline, CF Pharmtech Doubles Down on Novel Mechanisms for Pulmonary Delivery

CF PharmTech Doses First Subject in Phase I Trial for Inhaled Lung Disease Drug

MT Newswires Live

CF PharmTech completes first healthy volunteer dosing in Phase I trial of inhaled ILD therapy ICF004

Bulletin Express

CF Pharmtech Surges Over 10% Intraday as ICF001 Targets Four Indications

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/02652/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":6.64,"timestamp":1791360532004,"preClose":6.885,"halted":0,"volume":996400,"delay":0,"changeRate":-0.035584604212055206,"floatShares":323000000,"shares":432000000,"eps":0.0066,"marketStatus":"Not Yet Opened","change":-0.245,"latestTime":"10-07 16:08:52","open":6.8,"high":6.88,"low":6.35,"amount":6582313,"amplitude":0.076979,"askPrice":6.64,"askSize":2100,"bidPrice":6.615,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":0,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":6.885,"openAndCloseTimeList":[[1791336600000,1791345600000],[1791349200000,1791360000000]],"volumeRatio":0.6887589343444033,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":323000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.0066,"volumeRatio":0.6887589343444033,"shares":432000000,"dividePrice":0,"high":6.88,"amplitude":0.076979,"preClose":6.885,"low":6.35,"week52Low":6.35,"pbRate":"1.82","psRate":"5.61","week52High":48.8,"institutionHeld":0,"latestPrice":6.64,"committee":-0.68,"eps":0.0066,"divideRate":0,"volume":996400,"delay":0,"ttmEps":-0.018,"open":6.8,"prevYearClose":35,"prevWeekClose":6.85,"prevMonthClose":6.935,"prevQuarterClose":6.935,"fiveDayClose":6.985,"twentyDayClose":9.97,"sixtyDayClose":17.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-10-06","current":-368.888889,"percent":0.09465,"low":-715.224392,"twenty":389.086873,"median":481.475073,"eighty":2722.17681,"high":3595.964728,"avg":1287.289243,"sd":1272.279811,"marketCap":2797805034},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-05","current":2895.334441,"twenty":400.969089,"median":468.273561,"eighty":2926.706614,"marketCap":8327404730},{"date":"2026-06-12","current":2591.262092,"twenty":402.338985,"median":469.314298,"eighty":2919.612019,"marketCap":7447807192},{"date":"2026-06-18","current":2679.987141,"twenty":403.474666,"median":471.144686,"eighty":2910.923271,"marketCap":7719084937},{"date":"2026-06-26","current":2653.65777,"twenty":407.739322,"median":472.774581,"eighty":2903.774482,"marketCap":7608107678},{"date":"2026-07-03","current":2674.595079,"twenty":410.258066,"median":474.904398,"eighty":2905.018632,"marketCap":7673871980},{"date":"2026-07-10","current":2510.065653,"twenty":411.453021,"median":477.841604,"eighty":2898.212797,"marketCap":7192970522},{"date":"2026-07-17","current":2212.458756,"twenty":411.611884,"median":479.42962,"eighty":2892.703479,"marketCap":6362696210},{"date":"2026-07-24","current":2249.530522,"twenty":411.787912,"median":481.475073,"eighty":2888.435745,"marketCap":6470762659},{"date":"2026-07-31","current":2830.800739,"twenty":412.509722,"median":482.52515,"eighty":2884.270453,"marketCap":8158252159},{"date":"2026-08-07","current":2582.169982,"twenty":413.490204,"median":483.399827,"eighty":2872.355071,"marketCap":7456157987},{"date":"2026-08-14","current":2399.972298,"twenty":415.255724,"median":487.118208,"eighty":2848.370255,"marketCap":6938825440},{"date":"2026-08-21","current":2153.795127,"twenty":418.883405,"median":491.347467,"eighty":2826.107192,"marketCap":6240837082},{"date":"2026-08-28","current":2055.558094,"twenty":420.751477,"median":499.411825,"eighty":2817.123583,"marketCap":5957535925},{"date":"2026-09-04","current":-569.998069,"twenty":413.490204,"median":496.308733,"eighty":2813.278273,"marketCap":4516395257},{"date":"2026-09-11","current":-530.602158,"twenty":411.393271,"median":488.453269,"eighty":2785.197315,"marketCap":4209914329},{"date":"2026-09-18","current":-562.645514,"twenty":401.517047,"median":483.417787,"eighty":2737.610634,"marketCap":4469986257},{"date":"2026-09-25","current":-486.336524,"twenty":397.332771,"median":482.867142,"eighty":2725.301169,"marketCap":3856379052},{"date":"2026-10-02","current":-350.674033,"twenty":391.797785,"median":482.188522,"eighty":2723.288145,"marketCap":2783582350},{"date":"2026-10-06","current":-351.983075,"twenty":389.086873,"median":481.475073,"eighty":2722.17681,"marketCap":2797805034}],"updateTime":1791398491254},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1136289375","title":"CF PharmTech Spends HKD 499,600 to Buy Back 74,800 Shares on October 7","url":"https://stock-news.laohu8.com/highlight/detail?id=1136289375","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136289375?lang=en_us&edition=fundamental","pubTime":"2026-10-07 18:45","pubTimestamp":1791369917,"startTime":"0","endTime":"0","summary":"CF PharmTech (02652) has announced that on October 7, 2026, it spent HKD 499,600 to repurchase 74,800 shares.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112528698","title":"CF PharmTech repurchases 74,800 H-shares, boosting treasury stock to 2.02 million units","url":"https://stock-news.laohu8.com/highlight/detail?id=1112528698","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112528698?lang=en_us&edition=fundamental","pubTime":"2026-10-07 18:41","pubTimestamp":1791369684,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. disclosed that on 07 October 2026 it bought back 74,800 H-shares on the Hong Kong Stock Exchange under its authorised share‐repurchase mandate dated 26 June 2026. The shares were...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161269824","title":"CF PharmTech Reduces Outstanding H-Shares by 0.02% via HK$0.50 Million Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1161269824","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161269824?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:22","pubTimestamp":1791282147,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (CF PharmTech) reported a repurchase of 72,400 H-shares on 6 October 2026, executed on the Hong Kong Stock Exchange under its existing share-buyback mandate approved on 26 June...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154503406","title":"CF PharmTech Monthly Update: Share Capital Steady at RMB 433.73 Million; 337.80 Thousand H-Shares Moved to Treasury in September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1154503406","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154503406?lang=en_us&edition=fundamental","pubTime":"2026-10-06 16:42","pubTimestamp":1791276167,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (CF PharmTech) filed its statutory Monthly Return for the period ended 30 September 2026, confirming stable registered share capital and a modest expansion of treasury stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148205393","title":"Operating Cash Flow Turns Positive Sharply and Operating Efficiency Jumps Significantly: CF PharmTech (02652) Interim Report Releases Key Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=1148205393","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148205393?lang=en_us&edition=fundamental","pubTime":"2026-10-06 09:14","pubTimestamp":1791249258,"startTime":"0","endTime":"0","summary":"To judge whether a company is truly improving, there is one statement more honest than the income statement: the cash flow statement. CF PharmTech (02652) delivered a clear signal in its 2026 interim...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPHQ","159399","BK1191","02652","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134811713","title":"CF PharmTech Core Management Voluntarily Extends Share Lock-Up by Six Months","url":"https://stock-news.laohu8.com/highlight/detail?id=1134811713","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134811713?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:00","pubTimestamp":1791212428,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. announced that its co-founders and executive directors—Dr. Liang Bill Wenqing (Chairperson and CEO) and Dr. Li Li Bovet (Chief Scientific Officer)—have each signed voluntary...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121634500","title":"CF PharmTech Core Management Voluntarily Extends Share Lock-Up Period by Six Months","url":"https://stock-news.laohu8.com/highlight/detail?id=1121634500","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121634500?lang=en_us&edition=fundamental","pubTime":"2026-10-05 22:48","pubTimestamp":1791211691,"startTime":"0","endTime":"0","summary":"CF PharmTech (02652) has announced that it recently received voluntary undertakings from Dr. Liang Wenqing, co-founder, chairman, executive director, and chief executive officer, and Dr. Li Li,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178561525","title":"CF PharmTech Repurchases 71,800 Shares for HK$499,700 on October 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1178561525","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178561525?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:04","pubTimestamp":1790942651,"startTime":"0","endTime":"0","summary":"CF PharmTech (02652) announced that it repurchased 71,800 shares for HK$499,700 on October 2, 2026.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138541072","title":"CF PharmTech Buys Back 71,800 H Shares, Treasury Stock Climbs to 1.81 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1138541072","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138541072?lang=en_us&edition=fundamental","pubTime":"2026-10-02 20:00","pubTimestamp":1790942450,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. disclosed that it repurchased 71,800 H shares on 02 October 2026 via on-market transactions on the Hong Kong Stock Exchange. The buyback was executed within a price range of HKD...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148995454","title":"CF PHARMTECH: Bill Wenqing Liang Acquires Shares, Long Position Rises to 18.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148995454","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148995454?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:35","pubTimestamp":1790933704,"startTime":"0","endTime":"0","summary":"On September 28, 2026, Bill Wenqing Liang bought 25,100 H-shares of CF PHARMTECH on the SEHK open market at an average of HKD 7.2916 per share, involving about HKD 183,019, an on-exchange active...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196468457","title":"CF PHARMTECH: Pyramid Investment Limited Acquires Shares, Long Position Rises to 14.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196468457","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196468457?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:33","pubTimestamp":1790933623,"startTime":"0","endTime":"0","summary":"Pyramid Investment Limited bought 25,100 H-shares of CF PHARMTECH (02652) on the SEHK open market on September 28, 2026, at an average price of HKD 7.2916 per share, with a total consideration of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148681332","title":"CF PHARMTECH: Li Li Bovet Acquires Shares, Long Position Rises to 18.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148681332","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148681332?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:33","pubTimestamp":1790933590,"startTime":"0","endTime":"0","summary":"On September 28, 2026, Li Li Bovet's long position in CF PHARMTECH increased after Dr. LIANG Bill Wenqing, a party acting in concert with Li Li Bovet, purchased 25,100 H shares of the company on the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172159307","title":"CF PharmTech Buys Back 144,600 H Shares, Treasury Stock Rises to 1.73 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1172159307","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172159307?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:43","pubTimestamp":1790768590,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (CF PharmTech) disclosed a repurchase of 144,600 H shares on 30 September 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were bought at prices ranging...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189342248","title":"CF PharmTech Adds 67,900 H Shares to Treasury via HK$0.49 Million Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1189342248","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189342248?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:04","pubTimestamp":1790687068,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. executed an on-market repurchase of 67,900 H shares on 29 September 2026, paying a total of HK$0.49 million at prices ranging from HK$7.17 to HK$7.24 per share, with a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190768714","title":"CF PharmTech Spends HK$489,100 to Buy Back 67,900 Shares on September 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1190768714","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190768714?lang=en_us&edition=fundamental","pubTime":"2026-09-29 21:02","pubTimestamp":1790686935,"startTime":"0","endTime":"0","summary":"CF PharmTech (02652) announced that on September 29, 2026, the company spent HK$489,100 to repurchase 67,900 shares, at a repurchase price of HK$7.17 to HK$7.24 per share.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174155305","title":"CF PharmTech Repurchases 125,300 Shares for HK$948,800 on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1174155305","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174155305?lang=en_us&edition=fundamental","pubTime":"2026-09-28 20:02","pubTimestamp":1790596933,"startTime":"0","endTime":"0","summary":"CF PharmTech (02652) announced that on September 28, 2026, it repurchased 125,300 shares for HK$948,800.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197173820","title":"AI-Driven Innovation at the Source: Targeting a Globally Scarce Inhaled Anti-Inflammatory Pipeline, CF Pharmtech Doubles Down on Novel Mechanisms for Pulmonary Delivery","url":"https://stock-news.laohu8.com/highlight/detail?id=1197173820","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197173820?lang=en_us&edition=fundamental","pubTime":"2026-09-23 09:36","pubTimestamp":1790127386,"startTime":"0","endTime":"0","summary":"CF Pharmtech (02652) recently announced a research collaboration agreement with a tech enterprise founded by a team of scientists with backgrounds in relevant disciplines from a leading domestic...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","QTOC","CHAT","ARTY","BK1191","AIPO","02652","VTHR","159945"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669079118","title":"CF PharmTech Doses First Subject in Phase I Trial for Inhaled Lung Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2669079118","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669079118?lang=en_us&edition=fundamental","pubTime":"2026-09-22 12:17","pubTimestamp":1790050678,"startTime":"0","endTime":"0","summary":"CF PharmTech  has enrolled and dosed the first healthy subject in the Phase I clinical trial of ICF004, an inhaled drug being developed to treat interstitial lung disease.The Phase I trial will assess the safety, tolerability and pharmacokinetics of single and multiple doses in healthy subjects in China, according to a Monday Hong Kong bourse filing.ICF004 is designed to deliver the drug directly to the lungs to increase local exposure while reducing systemic exposure.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175867609","title":"CF PharmTech completes first healthy volunteer dosing in Phase I trial of inhaled ILD therapy ICF004","url":"https://stock-news.laohu8.com/highlight/detail?id=1175867609","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175867609?lang=en_us&edition=fundamental","pubTime":"2026-09-21 23:01","pubTimestamp":1790002905,"startTime":"0","endTime":"0","summary":"CF PharmTech announced the successful enrolment and dosing of the first healthy subject in its Phase I clinical trial evaluating ICF004, an inhalation powder developed for interstitial lung disease...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104672753","title":"CF Pharmtech Surges Over 10% Intraday as ICF001 Targets Four Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=1104672753","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104672753?lang=en_us&edition=fundamental","pubTime":"2026-09-14 11:30","pubTimestamp":1789356623,"startTime":"0","endTime":"0","summary":"Shares of CF Pharmtech (02652) climbed sharply this morning, hitting an intraday peak with a gain exceeding 10%. As of the time of writing, the stock has pared gains to trade up 1.06% at HKD 10.47,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":133,"code":"91000000","status":"200"}]}}